Texas Capital analyst Eric Wold raised the firm’s price target on Imax (IMAX) to $47 from $43 and keeps a Buy rating on the shares following the investor day. The firm left “increasingly confident” that Imax is well positioned for continued global box office share gains. The brand is “driving past key demand inflection points” from all industry participants, including studios, exhibitors, and moviegoers, the analyst tells investors in a research note. Texas says Imax issued 2026 guidance and three-year financial targets that were well ahead of expectations.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- Imax up 6% as investor day continues
- Imax shares three-year financial targets at investor day
- ‘Zootopia 2’ Debut Gives Disney Stock The Wildly Needed $556M Lifeline
- IMAX Upgraded to Neutral: Strategic Value and Growth Prospects Drive Increased Price Target
- Imax upgraded to Neutral from Sell at Goldman Sachs